105
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

, , , , &
Pages 279-288 | Published online: 08 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

P. Prabitha, Dhivya Shanmugarajan, T. Durai Ananda Kumar & B. R. Prashantha Kumar. (2022) Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates. Journal of Biomolecular Structure and Dynamics 40:6, pages 2663-2673.
Read now
Virendra Nath, Rohini Agrawal & Vipin Kumar. (2020) Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors –α/γ dual agonists for treatment of metabolic disorders. Journal of Biomolecular Structure and Dynamics 38:2, pages 511-523.
Read now
Xue-Jiao Wang, Jun Zhang, Shu-Qing Wang, Wei-Ren Xu, Xian-Chao Cheng & Run-Ling Wang. (2014) Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone. Drug Design, Development and Therapy 8, pages 2255-2262.
Read now
Maliheh Safavi, Alireza Foroumadi & Mohammad Abdollahi. (2013) The importance of synthetic drugs for type 2 diabetes drug discovery. Expert Opinion on Drug Discovery 8:11, pages 1339-1363.
Read now

Articles from other publishers (5)

Kuo-Chen Chou. (2021) The Remarkable Impacts of Gordon Life Science Institute. Natural Science 13:03, pages 43-75.
Crossref
. (2019) The Cradle of Gordon Life Science Institute and Its Development and Driving Force. International Journal of Biology and Genetics, pages 1-28.
Crossref
Rajesh B. Patil, Euzebio G. Barbosa, Jaiprakash N. Sangshetti, Vishal P. Zambre & Sanjay D. Sawant. (2018) Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies. Molecular Diversity 22:3, pages 575-583.
Crossref
Hong-Lian Li, Ying Ma, Ying Ma, Yu Li, Xiu-Bo Chen, Wei-Li Dong & Run-Ling Wang. (2017) The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches. Oncotarget 8:20, pages 33225-33240.
Crossref
Yuanyuan Jin, Linhu Li, Zhaoyong Yang, Mingliang Liu, Huiyuan Guo & Weiyi Shen. (2017) The discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study. Oncotarget 8:15, pages 24635-24643.
Crossref